The Rise and Fall of the Insulin Pricing Bubble

William B Feldman^{1

2

3}, Benjamin N Rome^{1

3}

Affiliations

¹ Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
² Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
³ Harvard Medical School, Boston, Massachusetts.

Free article

Comment

William B Feldman et al. JAMA Netw Open. 2023.

Free article

. 2023 Jun 1;6(6):e2318074.

doi: 10.1001/jamanetworkopen.2023.18074.

William B Feldman^{1

2

3}, Benjamin N Rome^{1

3}

¹ Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
² Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
³ Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019.
Dickson SR, Gabriel N, Gellad WF, Hernandez I. Dickson SR, et al. JAMA Netw Open. 2023 Jun 1;6(6):e2318145. doi: 10.1001/jamanetworkopen.2023.18145. JAMA Netw Open. 2023. PMID: 37314806 Free PMC article.